drugset / Trial / NCT00450996

Analysis of a Beneficial Effect of Prolonges Topical Steroid Treatment After Low-risk Penetrating Keratoplasty

NCT00450996

RandomizedParallel-groupOpen-labelPrevention

Summary

PURPOSE: To assess the impact of duration of topical steroid treatment on the incidence of endothelial graft rejection following normal-risk penetrating keratoplasty (PK). DESIGN: Prospective, institutional, longitudinal, randomized interventional trial including 406 eyes (age: 52 \>= 19 years; follow-up: 42 \>= 18months). METHODS: Postoperative treatment started with prednisolone acetate 1% eye drops five times daily and was tapered over the first 6 months. Patients were then randomised into either short-term (stop topical steroid treatment) or long-term treatment (continue steroids once daily until 12 months).

Timeline

Start
1999-01
Primary completion
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Prednisolone Other / unclassified 1 % Topical

Indications